CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Supply)
Duration
4 year (est.)
Value
£608M
Sector
HEALTH
Published
03 Apr 2024
Delivery
01 Apr 2024 to 31 Mar 2028 (est.)
Deadline
n/a

Concepts

Location

Please refer to Document 3, Schedule 8 in the ITO Documents for the list of purchasing points

Geochart for 2 buyers and 6 suppliers
NHS England
Quantum Pharmaceutical
Lloydspharmacy Clinical Homecare
Baxter Healthcare
Sciensus Pharma Services
Qualasept
Ith Pharma
+−
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

2 buyers

6 suppliers

Description

Proposed NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

Total Quantity or Scope

CM/PHR/22/5686- NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) 1 April 2024 to 31 March 2028 -East, SouthEast, London, NOFE

Award Detail

1 Quantum Pharmaceutical (Burnopfield)
  • Num offers: 6
  • Value: £1
  • Contractor is an SME.
2 Lloydspharmacy Clinical Homecare (Coventry)
  • Num offers: 6
  • Value: £1
3 Baxter Healthcare (Norfolk)
  • Num offers: 6
  • Value: £1
4 Sciensus Pharma Services (Staffordshire)
  • Num offers: 6
  • Value: £1
5 Qualasept (Wilshire)
  • Num offers: 6
  • Value: £1
6 Ith Pharma (London)
  • Num offers: 6
  • Value: £1

Award Criteria

PRICE _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Reference

Domains